J Kermanshah Univ Med Sci

Image Credit:J Kermanshah Univ Med Sci

Determinants of Diabetic Foot Ulcer Severity: The Role of Arterial Occlusion and Glycemic Markers

Author(s):
Kiana ShiraniKiana ShiraniKiana Shirani ORCID1, Mohammad Amin AlinejadMohammad Amin AlinejadMohammad Amin Alinejad ORCID2,*, Farzin KhorvashFarzin Khorvash1, Mohammad Reza MaracyMohammad Reza MaracyMohammad Reza Maracy ORCID3
1Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2Isfahan University of Medical Sciences, Isfahan, Iran
3Department of Epidemiology and Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran

Journal of Kermanshah University of Medical Sciences:Vol. 29, issue 4; e167105
Published online:Dec 16, 2025
Article type:Research Article
Received:Oct 18, 2025
Accepted:Dec 10, 2025
How to Cite:Shirani K, Alinejad M A, Khorvash F, Maracy M R. Determinants of Diabetic Foot Ulcer Severity: The Role of Arterial Occlusion and Glycemic Markers.J Kermanshah Univ Med Sci.2025;29(4):e167105.https://doi.org/10.5812/jkums-167105.

Abstract

Background:

Diabetic foot ulcer (DFU) is a serious complication of diabetes mellitus, often leading to infection, hospitalization, and lower limb amputation. Peripheral arterial disease (PAD) and poor glycemic control are considered important risk factors of DFU severity.

Objectives:

this study aimed to assess the association between arterial occlusion, glycated hemoglobin (HbA1C), hemoglobin (Hb) concentration, age, and sex and the severity of DFU.

Methods:

In this cross-sectional study, we evaluated 205 patients with DFU who were admitted to Alzahra Hospital, Isfahan, between March 2021 and March 2023. Demographic data, arterial occlusion status, HbA1C, Hb, and DFU severity were extracted from medical records. Statistical analyses were done using analysis of variance (ANOVA), chi-square, and multiple ordinal logistic regression.

Results:

Among 205 patients (68.8% male; mean age 59.5 ± 11.1 years), DFU severity was mild in 32.2%, moderate in 56.6%, and severe in 11.2%. Arterial occlusion was present in 65.2% of those assessed and was significantly associated with higher DFU (OR = 3.47; 95% Cl: 1.26 - 9.58; P < 0.05). Higher HbA1C levels were also associated with increased DFU severity (OR = 1.44; 95% CI: 1.16 - 1.77; P < 0.05), whereas elevated Hb levels were independently correlated with reduced odds of DFU (OR = 0.68; 95% Cl: 0.52 - 0.88; P < 0.05). Age and sex showed no significant association with DFU severity.

Conclusions:

Arterial occlusion, HbA1C, and Hb are associated with DFU severity. These findings underscore the potential relevance of vascular assessment, glycemic control, and anemia monitoring in the clinical evaluation of patients with DFU.

1. Background

Diabetes mellitus (DM) is a disorder of carbohydrate metabolism that is characterized by persistent hyperglycemia due to impaired insulin secretion, increased peripheral insulin resistance, or both (1). Diabetes mellitus is associated with numerous complications, including microvascular, macrovascular, and neurological disorders (2). Among these, diabetic foot ulcer (DFU) is a severe complication often coexisting with peripheral neuropathy and peripheral arterial disease (PAD), leading to infection, hospitalization, and lower limb amputation (3-5).

Peripheral arterial disease impairs wound healing in approximately 50% of affected individuals, exacerbating DFU severity (4). Peripheral arterial disease is reported in 50 - 61% of patients with DFU, and its presence increases the risk of non-healing ulcers, severe infection, and amputation (6, 7). Ischemia due to arterial occlusion may exacerbate tissue loss and complicate wound healing (8). Investigations on the impact of glycated hemoglobin (HbA1C) on DFU outcomes have produced mixed results; some studies demonstrated no correlation between poor glycemic control and DFU severity (9, 10). In a study of 99 patients, HbA1C did not influence recovery rates but was significantly associated with recovery duration (11). Another study demonstrated that higher levels of HbA1C were associated with an increased risk of amputations and progressive tissue loss (12). Chronic kidney disease, Systemic inflammation, functional hematinic deficiencies, erythropoietin resistance and reduced red cell survival may cause anemia in diabetic patients (13). A recent systematic review and meta-analysis demonstrated a prevalence of 49.5% in patients with mild to moderate DFU, compared with 73% in those with severe DFU (14). In another study involving 323 patients, anemia of chronic disease secondary to DFU was identified as the predominant etiology of anemia in this population (15). Overall, these studies indicated a strong association between anemia and DFU severity and suggest that anemia is linked to poorer clinical outcomes in affected patients (14, 15).

2. Objectives

The burden of DM, DFU, and diabetic foot infections (DFIs) has been rising rapidly in Iran, including in Isfahan, where diabetes prevalence is among the highest in the country (16, 17). Despite the high clinical and economic impact of DFU, local data on the determinants of ulcer severity, particularly the roles of arterial occlusion, HbA1C, and hemoglobin (Hb) remain limited. Understanding these associations in our regional population is essential for early risk stratification, optimizing management strategies, and reducing amputation rates. This study aimed to investigate the relationships between arterial occlusion, HbA1C, Hb levels, age, and sex and the severity of DFUs among hospitalized patients in Isfahan, Iran.

3. Methods

This cross-sectional study was conducted at Alzahra Hospital, Isfahan, Iran. The study population consisted of 205 patients with DFU who were admitted to Alzahra Hospital between March 2021 and March 2023. A data collection form was developed to record variables including age, sex, arterial occlusion, HbA1C, Hb, and DFU severity.

Diabetic foot ulcer severity was assessed according to the IDSA classification (18), as documented in medical records by a physician. Ulcers were categorized into three groups: Mild, moderate, and severe.

Arterial occlusion status in the lower limbs was determined by reviewing arterial Doppler ultrasonography reports available in the patients’ medical records. The patients had undergone arterial Doppler ultrasonography during hospitalization.

Glycated hemoglobin and Hb values were extracted from medical records; most HbA1C measurements were performed at hospital admission using standard laboratory procedures. Demographic variables (age and sex) were also recorded. Intervening factors such as smoking status, blood pressure, comorbidities, and medications were not controlled in this retrospective study and are acknowledged as potential confounders. Data were entered into a standardized checklist and subsequently analyzed using SPSS version 26 (IBM Corp., Armonk, NY, USA). Descriptive statistics were reported and inferential analysis were performed using one-way analysis of variance (ANOVA), chi-square test, and multiple ordinal logistic regression. We note that the number of patients in the severe DFU group was relatively small, which may affect the statistical power and interpretation of results for this subgroup. A two-tailed P-value < 0.05 was considered statistically significant.

The study protocol was approved by the Ethics Committee of Isfahan University of Medical Sciences (approval number: IR.MUI.MED.REC.1402.378). The study involved retrospective review of medical records without direct patient contact. All data were anonymized and handled confidentially. No financial compensation was received from any individuals or organizations, and there was no conflict of interest.

4. Results

A total of 205 patients were included, of whom 141 (68.8%) were male, with a mean age of 59.5  ±  11.1 years. Diabetic foot ulcer severity was mild in 32.2%, moderate in 56.6%, and severe in 11.2% of patients. Of the 184 patients assessed by arterial Doppler ultrasonography, 65.2% had arterial occlusion.

Normality tests for non-categorical variables across the different DFU severity groups indicated that the P-values for both skewness and kurtosis were above the 0.05 threshold in all cases, suggesting no significant deviation from normal distribution which supports the use of parametric statistical methods in subsequent analyses (Table 1).

Table 1.Skewness and Kurtosis Tests for Normality (Joint Test)
DFUObsPr (skewness)Pr (Kurtosis)Adj Chi2(2)Prob > Chi2
Mild
HbA1C260.80340.13712.510.2858
Age660.44820.79460.660.7195
Hb660.76380.90340.110.9488
Moderate
HbA1C590.32810.07614.230.1204
Age1160.96430.61080.260.8777
Hb1130.14420.29393.310.1910
Severe
HbA1C90.24510.55712.000.3680
Age230.95400.05004.090.1296
Hb230.48370.80280.580.7487

Abbreviations: DFU, diabetic foot ulcer; Hb, hemoglobin; HbA1C, glycated hemoglobin.

Table 2 demonstrates the characteristics of included population based on the severity of DFU. The mean age did not significantly differ among the groups (P = 0.3448). The mean HbA1C levels differed significantly within the three groups (P < 0.05). Hb levels differed significantly across the severity groups (P < 0.05). The mild group had the highest mean Hb (11.2 ± 1.8 g/dL), followed by the moderate group (10.2 ± 2.1 g/dL) and the severe group (8.8 ± 1.8 g/dL). No significant difference was found in the sex distribution between groups (P = 0.556). The presence of arterial occlusion was significantly more common in patients with moderate (71.0%) and severe (80.0%) DFU compared to the mild group (49.1%) (P < 0.05).

Table 2.Patients’ Characteristics Based on Severity of Diabetic Foot Ulcer
DFUMild (1)Moderate (2)Severe (3)Test; P-Value
AgeF(2,202) = 1.1; P = 0.3448
n6611623
Mean ± SD59.4 ± 10.258.9 ± 11.462.7 ± 12.3
Min-max34 - 8032 - 9242 - 84
HbA1CF(2,91) = 4.4; P < 0.05; P (1,2) a < 0.05
n26599
Mean ± SD8.4 ± 2.110.1 ± 2.49.8 ± 2.5
Min - max5.2 - 12.45.8 - 15.35.8 - 12.4
HbF(2,199) = 14.6; P < 0.05; P (1,2)a < 0.05; P (1,3)a < 0.05; P (2,3)a < 0.05
n6611323
Mean ± SD11.2 ± 1.810.2 ± 2.18.8 ± 1.8
Min - max7.1 - 16.45.5 - 15.56 - 12.9
Sex; No. (%)Chi2(2) = 1.17; P = .556
Female 18 (27.3)37 (31.9)9 (39.1)
Male 48 (72.7)79 (68.1)14 (60.9)
Arterial occlusion; No. (%)Chi2(2) = 10.0; P < 0.05
Yes 28 (49.1)76 (71.0)16 (80.0)
No 29 (50.9)31 (29.0)4 (20.0)

Abbreviations: DFU, diabetic foot ulcer; Hb, hemoglobin; HbA1C, glycated hemoglobin.

a Post-hoc Bonferroni test.

According to Table 3, ordinal logistic regression analyses were employed to evaluate the association between characteristics and DFU severity. In the univariate ordinal logistic regression, higher HbA1C levels were significantly associated with increased odds of more severe DFU (OR = 1.25; 95% CI: 1.04 - 1.49; P < 0.05), while higher Hb levels were protective, with lower odds of DFU (OR = 0.69; 95% Cl: 0.60 - 0.80; P < 0.05). The presence of arterial occlusion was also significantly linked with increased risk of DFU (OR = 2.64; 95% CI: 1.43 - 4.89; P < 0.05).

Table 3.Association of Some Characteristics on Severity of Diabetic Foot Ulcer Using Ordinal Logistic Regression
DFUUnivariate Ordinal Logistic RegressionMultiple Ordinal Logistic Regression
OR (95% CI)P-ValueOR (95% CI)P-Value
Age 1.01 (0.98 - 1.03)0.4781.005 (0.96 - 1.05)0.8
HbA1C1.25 (1.04 - 1.49)< 0.051.44 (1.16 - 1.77)< 0.05
Hb0.69 (0.60 - 0.80)< 0.050.68 (0.52 - 0.88)< 0.05
Arterial occlusion (yes)2.64 (1.43 - 4.89)< 0.053.47 (1.26 - 9.58)< 0.05
Sex (male)1.37 (0.76 - 2.45)0.2952.35 (0.77 - 7.16)0.13

Abbreviations: DFU, diabetic foot ulcer; Hb, hemoglobin; OR, odds ratio; CI, confidence interval; HbA1C, glycated hemoglobin.

In the multiple ordinal logistic regression model, HbA1C remained associated with DFU severity, with each 1% increase in HbA1C corresponding 44% higher odds of being in a more severe DFU category (OR = 1.44; 95% CI: 1.16 - 1.77; P < 0.05). Higher Hb levels were significantly associated with lower DFU severity, with each 1g/dL increase in Hb linked to 32% lower odds of more severe DFU (OR = 0.68; 95% Cl: 0.52 - 0.88; P < 0.05). In addition, patients with arterial occlusion had 3.47 times higher odds of more severe DFU compared to those without arterial occlusion (OR = 3.47; 95% Cl: 1.26 - 9.58; P < 0.05) (Table 3).

5. Discussion

In the present study, we found that arterial occlusion was strongly associated with DFU severity. Elevated HbA1C was also associated with increased severity, while Hb levels showed an inverse relationship with DFU severity. Age and sex were not significantly associated with DFU severity in any analysis.

The robust association between arterial occlusion and DFU severity observed in our study aligns with existing literature. Several studies have documented a correlation between PAD and an increased risk of non-healing ulcers, infection, and major limb amputation (7) The prevalence of PAD in patients with DFU is reported to range from 50% to 61% (6, 7), and our findings indicate a prevalence of 65.2% for arterial occlusion. Another study showed that patients with PAD have approximately threefold higher odds of developing DFUs compared to individuals without PAD (19). Our study identified a significant association between arterial occlusion and the severity of DFUs, with an odds ratio of 3.47. This finding highlights the potential importance of arterial occlusion in relation to DFU severity.

Regarding HbA1C levels, a recent research by Arnold et al. (20) demonstrated that poor glycemic control and high HbA1C levels are major risk factors for both microvascular and macrovascular complications in diabetes. Dogan (21) reported a significant association between higher levels of HbA1C levels and the formation of deeper and larger wounds, while Fesseha et al. (10) found no association between baseline HbA1C and wound healing. In our study, patients in the moderate group exhibited significantly higher HbA1c levels compared with those in the mild group; however, the severe group did not differ significantly from the other groups. The limited sample size of the severe group may account for this lack of statistical significance. Overall, using multiple ordinal logistic regression, we observed that each 1% increase in HbA1c was associated with 44% higher odds of more severe DFUs. This association is consistent with the proposed effects of hyperglycemia on immune function, delayed wound healing, and increased susceptibility to infection (22).

Hb levels were significantly lower in patients with more severe DFUs. A study of 323 patients demonstrated chronic disease secondary to DFU as the leading cause of anemia in DFU patients (15). Impaired nutrient and oxygen delivery to the ulcer site may compromise tissue repair and delay wound healing (23). Thus, previous studies suggest that severe DFU may exacerbate anemia, and anemia, in turn, may contribute to worsening DFU, potentially creating a vicious cycle (Figure 1) (14, 15).

Vicious cycle between anemia and diabetic foot ulcer (DFU)
Figure 1.

Vicious cycle between anemia and diabetic foot ulcer (DFU)

The mean of age of our study population was 59.54  ±  11.13 years, with approximately 80% of participants over 50 years of age. Despite this, no significant relationship between age and DFU severity was observed. Syauta et al. (24) similarly found no significant association between age and DFU severity. Conversely, some studies have reported an association between age and occurrence of DFUs (25, 26) and another research suggested that wound healing may be more difficult in older patients with DFU (27). Similarly, sex was not significantly associated with DFU severity in our cohort, despite the predominance of men (68.8%) in the sample and reports from some other studies suggesting worse ulcer outcomes in men (28). The absence of a significant association between age or sex and DFU may result from study limitations, including relatively sample size and the specific population included. Another potential explanation is that age and sex may be related to the occurrence of DFUs, but not to their severity.

In our country, several studies have investigated the predictors and risk factors of DFU complications. A case-control study conducted in Zahedan, Iran, found that male sex, older age, and higher HbA1C levels were significantly associated with both the incidence and severity of DFU (29). In contrast, a cohort study from Ahvaz, Iran, reported that male sex was a significant risk factor for DFU progression, whereas HbA1C was not a significant predictor (30). These inconsistencies among studies highlight the necessity of conducting region-specific research to better understand local risk factors and patterns of DFU.

The present study has several limitations. Its cross-sectional design limits the ability to draw causal inferences. Incomplete HbA1c data may also have reduced the precision of our estimates. Additionally, the number of patients with severe DFU was relatively small, which may have limited the statistical power to detect differences in this subgroup and should be considered when interpreting the results. Because the study was conducted in a single tertiary care center, the findings may not be fully generalizable to broader or more diverse populations. Additionally, cultural factors such as healthcare access, lifestyle, and patient awareness may influence ulcer severity and outcomes, which should be considered when generalizing the findings. Future prospective studies with larger and more balanced sample sizes across DFU severity categories, multi-center recruitment, and standardized HbA1c assessment are needed to better elucidate these associations.

In conclusion, arterial occlusion, poor glycemic control (high HbA1c), and anemia are key factors associated with DFU severity. These results underscore the importance of comprehensive assessment and management of vascular health, glycemia, and Hb levels to prevent progression of DFUs.

Acknowledgments

Footnotes

References

  • 1.
    Inzucchi SE, Lupsa B. Clinical presentation, diagnosis, and initial evaluation of diabetes mellitus in adults. UpToDate; 2021. Available from: https://doctor2023.jumedicine.com/wp-content/uploads/sites/15/2025/07/Clinical-presentation-diagnosis-and-initial-evaluation-of-diabetes-mellitus-in.pdf.
  • 2.
    Ghasempour Dabaghi G, Rabiee Rad M, Mortaheb M, Darouei B, Amani-Beni R, Mazaheri-Tehrani S, et al. The Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Outcomes in Patients With Diabetes: A Systematic Review and Meta-Analysis. Cardiol Rev. 2025;33(3):202-11. [PubMed ID: 39531515]. https://doi.org/10.1097/CRD.0000000000000820.
  • 3.
    Shahidi S, Kabiri Naeini E, Mazaheri-Tehrani S. Cilostazol-induced Acute Kidney Injury in A Patient With Diabetic Foot Ulcer: A Case Report and Review of Literature. Iran J Kidney Dis. 2022;16(5):311-4. [PubMed ID: 36178866].
  • 4.
    Bellomo TR, Lee S, McCarthy M, Tong KPS, Ferreira SS, Cheung TP, et al. Management of the diabetic foot. Semin Vasc Surg. 2022;35(2):219-27. [PubMed ID: 35672112]. https://doi.org/10.1053/j.semvascsurg.2022.04.002.
  • 5.
    Senneville E, Lipsky BA, Abbas ZG, Aragon-Sanchez J, Diggle M, Embil JM, et al. Diagnosis of infection in the foot in diabetes: a systematic review. Diabetes Metab Res Rev. 2020;36 Suppl 1. e3281. [PubMed ID: 32176440]. https://doi.org/10.1002/dmrr.3281.
  • 6.
    Janbakhsh A, Abedinfam M, Sobhiyeh MR, Rezaie M, Aslani PS, Vaziri S, et al. Prevalence of peripheral artery disease in patients with infectious diabetic foot ulcer in Imam Reza Hospital in Kermanshah during 2019-2020. J Educ Health Promot. 2021;10(1):170. [PubMed ID: 34250104]. [PubMed Central ID: PMC8249957]. https://doi.org/10.4103/jehp.jehp_907_20.
  • 7.
    Hinchliffe RJ, Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 Suppl 1. e3276. [PubMed ID: 31958217]. https://doi.org/10.1002/dmrr.3276.
  • 8.
    Stoberock K, Kaschwich M, Nicolay SS, Mahmoud N, Heidemann F, Riess HC, et al. The interrelationship between diabetes mellitus and peripheral arterial disease. Vasa. 2021;50(5):323-30. [PubMed ID: 33175668]. https://doi.org/10.1024/0301-1526/a000925.
  • 9.
    Bahati R, Kitua D, Selestine L, Mwanga A, Urio M, McHele G, et al. Factors influencing the severity of diabetic foot ulcers: a cross-sectional study. BMC Endocr Disord. 2025;25(1):76. [PubMed ID: 40108563]. [PubMed Central ID: PMC11924770]. https://doi.org/10.1186/s12902-024-01785-0.
  • 10.
    Fesseha BK, Abularrage CJ, Hines KF, Sherman R, Frost P, Langan S, et al. Association of Hemoglobin A(1c) and Wound Healing in Diabetic Foot Ulcers. Diabetes Care. 2018;41(7):1478-85. [PubMed ID: 29661917]. [PubMed Central ID: PMC6014539]. https://doi.org/10.2337/dc17-1683.
  • 11.
    Vella L, Gatt A, Formosa C. Does Baseline Hemoglobin A(1c) Level Predict Diabetic Foot Ulcer Outcome or Wound Healing Time? J Am Podiatr Med Assoc. 2017;107(4):272-9. [PubMed ID: 28880596]. https://doi.org/10.7547/15-176.
  • 12.
    Akyuz S, Bahcecioglu Mutlu AB, Guven HE, Basak AM, Yilmaz KB. Elevated HbA1c level associated with disease severity and surgical extension in diabetic foot patients. Ulus Travma Acil Cerrahi Derg. 2023;29(9):1013-8. [PubMed ID: 37681727]. [PubMed Central ID: PMC10560815]. https://doi.org/10.14744/tjtes.2023.08939.
  • 13.
    Williams A, Bissinger R, Shamaa H, Patel S, Bourne L, Artunc F, et al. Pathophysiology of Red Blood Cell Dysfunction in Diabetes and Its Complications. Pathophysiology. 2023;30(3):327-45. [PubMed ID: 37606388]. [PubMed Central ID: PMC10443300]. https://doi.org/10.3390/pathophysiology30030026.
  • 14.
    Yammine K, Hayek F, Assi C. Is there an association between anemia and diabetic foot ulcers? A systematic review and meta-analysis. Wound Repair Regen. 2021;29(3):432-42. [PubMed ID: 33591644]. https://doi.org/10.1111/wrr.12902.
  • 15.
    Kumar R, Singh SK, Agrawal NK, Kumar U, Kumar S, C S, et al. The Prevalence of Anemia in Hospitalized Patients With Diabetic Foot Ulcer (DFU) and the Relationship Between the Severity of Anemia and the Severity of DFU. Cureus. 2023;15(7). e41922. https://doi.org/10.7759/cureus.41922.
  • 16.
    Hashempour R, MirHashemi S, Mollajafari F, Damiri S, ArabAhmadi A, Raei B. Economic burden of diabetic foot ulcer: a case of Iran. BMC Health Serv Res. 2024;24(1):363. [PubMed ID: 38515182]. [PubMed Central ID: PMC10958898]. https://doi.org/10.1186/s12913-024-10873-9.
  • 17.
    Amini MR, Sanjari M, Mohajeri Tehrani MR, Nasli E, Yazdanpanah L, Mousavi Z, et al. Evaluation of foot self-care status and foot screening problems in patients with diabetes in Iran: a national multicenter study. BMC Endocr Disord. 2023;23(1):178. [PubMed ID: 37605234]. [PubMed Central ID: PMC10440894]. https://doi.org/10.1186/s12902-023-01401-7.
  • 18.
    Armstrong DG, Peters EJ. Classification of wounds of the diabetic foot. Curr Diab Rep. 2001;1(3):233-8. [PubMed ID: 12643204]. https://doi.org/10.1007/s11892-001-0039-1.
  • 19.
    Tresierra-Ayala MÁ, García Rojas A. Association between peripheral arterial disease and diabetic foot ulcers in patients with diabetes mellitus type 2. Med Univ. 2017;19(76):123-6. https://doi.org/10.1016/j.rmu.2017.07.002.
  • 20.
    Arnold SV, Khunti K, Tang F, Chen H, Cid-Ruzafa J, Cooper A, et al. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study. Am Heart J. 2022;243:232-9. [PubMed ID: 34666013]. https://doi.org/10.1016/j.ahj.2021.10.181.
  • 21.
    Dogan M. Is high level of HbA1C an indicator for extended period of antibiotherapy in diabetic foot ulcers? Northern Clin Istanbul. 2018;6(1):21-7. https://doi.org/10.14744/nci.2018.25582.
  • 22.
    Lee H, Kim MJ, Lee IK, Hong CW, Jeon JH. Impact of hyperglycemia on immune cell function: a comprehensive review. Diabetol Int. 2024;15(4):745-60. [PubMed ID: 39469566]. [PubMed Central ID: PMC11512986]. https://doi.org/10.1007/s13340-024-00741-6.
  • 23.
    Wang R, Gu S, Kim YH, Lee A, Lin H, Jiang D. Diabetic Wound Repair: From Mechanism to Therapeutic Opportunities. MedComm (2020). 2025;6(10). e70406. [PubMed ID: 41030912]. [PubMed Central ID: PMC12477442]. https://doi.org/10.1002/mco2.70406.
  • 24.
    Syauta D, Hendarto J, Mariana N; Mulawardi; Prihantono; Sulmiati, et al. Risk factors affecting the degree of diabetic foot ulcers according to Wagner classification in diabetic foot patients. Med Clin Practica. 2021;4. https://doi.org/10.1016/j.mcpsp.2021.100231.
  • 25.
    Ghobadi A, Ahmadi Sarbarzeh P, Jalilian M, Abdi A, Manouchehri S. Evaluation of Factors Affecting the Severity of Diabetic Foot Ulcer in Patients with Diabetes Referred to a Diabetes Centre in Kermanshah. Diabetes Metab Syndr Obes. 2020;13:693-703. [PubMed ID: 32214832]. [PubMed Central ID: PMC7078779]. https://doi.org/10.2147/DMSO.S242431.
  • 26.
    Vahwere BM, Ssebuufu R, Namatovu A, Kyamanywa P, Ntulume I, Mugwano I, et al. Factors associated with severity and anatomical distribution of diabetic foot ulcer in Uganda: a multicenter cross-sectional study. BMC Public Health. 2023;23(1):463. [PubMed ID: 36899359]. [PubMed Central ID: PMC9999659]. https://doi.org/10.1186/s12889-023-15383-7.
  • 27.
    Sanjeeviraj S, Subburaj A, Aluri S, Thakku Sekar BR, Jalan M, Joseph AG. A Cohort Study on the Outcome of Diabetic Foot Ulcers. Cureus. 2023;15(10). e48030. [PubMed ID: 38034176]. [PubMed Central ID: PMC10687807]. https://doi.org/10.7759/cureus.48030.
  • 28.
    Vanherwegen AS, Lauwers P, Lavens A, Doggen K, Dirinck E, Initiative for Quality I, et al. Sex differences in diabetic foot ulcer severity and outcome in Belgium. PLoS One. 2023;18(2). e0281886. [PubMed ID: 36795662]. [PubMed Central ID: PMC9934352]. https://doi.org/10.1371/journal.pone.0281886.
  • 29.
    Danesh H, Maleknejad A, Emami MA, Keykha M, Bahmani A. Evaluation and Comparison of HbA1C Level in Diabetic Patients with and without Foot Ulcer: A Case control Study. Iran J Emergency Med. 2024;11(1). e1.
  • 30.
    Yazdanpanah L, Shahbazian H, Hesam S, Ahmadi B, Zamani AM. Two-year incidence and risk factors of diabetic foot ulcer: second phase report of Ahvaz diabetic foot cohort (ADFC) study. BMC Endocr Disord. 2024;24(1):46. [PubMed ID: 38622562]. [PubMed Central ID: PMC11017491]. https://doi.org/10.1186/s12902-024-01572-x.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles